For instance, the non-cytopathic KUN vector expressing the granulocyte macrophage-stimulating factor (GM-CSF)—when administered intratumorally to BALB/c mice with CT26 xenografts—induced CD8+ T cell responses, resulted in tumor regression and in cure of more than 50% of immunized animals [102]. The gene discussed is CD8A; the disease is neoplasm.